Article

ASCO Releases A Payment Reform Model

ASCO says that it's Patient-Centered Oncology Payment model meets the criteria for an Alternative Payment Model as defined by Congress in the Medicare Access and CHIP Reauthorization Act of 2015, which replaced the Sustainable Growth Rate formula.

The American Society of Clinical Oncology (ASCO) has released the Patient-Centered Oncology Payment (PCOP) model, which expands on ASCO's payment reform proposal from last year. The organization claims that PCOP qualifies as an Alternative Payment Model as defined by the Medicare Access and CHIP Reauthorization Act of 2015 that was released by Congress last month to replace Medicare's widely criticized Sustainable Growth Rate formula.

According to ASCO PCOP will address the following:

  • Education and support to help patients make the best choices about their cancer treatment,
  • Rapid response for patients experiencing problems during treatment to help avoid emergency department visits or hospitalizations,
  • Care coordination with other healthcare providers, and
  • Continued support to patients after active treatment ends

Read the complete news release by ASCO: http://bit.ly/1Gs2ygI

Related Videos
Lalan Wilfong, MD
Katherine Baker, MD, MMHC
Nini Wu, MD, MBA
Casey Koch, PharmD, sitting for a video interview
Andrew Chapman, DO
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo